HYPERBILIRUBINEMIA.ppt
-
Upload
alexisroye -
Category
Documents
-
view
213 -
download
0
Transcript of HYPERBILIRUBINEMIA.ppt
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
1/30
Management of
Hyperbilirubinemiain the newborn infant 35or more weeks of gestation
Clinical Practice Guideline
American Academy of Pediatrics
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
2/30
BILIRUBIN
............................................By-product of heme metabolism
Excreted through stool and urine
Fat-soluble
Hyperbilirubinemia
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
3/30
JAUNDICE
............................................ Yellowish discoloration of the skin and sclera
Common in most newborn infants
Benign but has potential for bilirubin toxicity =
KERNICTERUS
Risk factors
Management
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
4/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
5/30
K E Y E L E M E N T S
Promote and support successfulbreastfeeding
Establish protocols in the theidentification and evaluation of
hyperbilirubinemia
Measure the total serum bilirubin(TSB)
or transcutaneous bilirubin (TcB) level on
infants jaundiced within 24 hours
1
2
3
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
6/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
7/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
8/30
K E Y E L E M E N T S
Recognize that visual estimation of the degree of
jaundice can lead to errors, particularly in darkly
pigmented infants
Interpret all bilirubin levels in infant's age inhours
Recognize that infants at less than 38 weeks'particularly those who are breastfed, are at
higher risk of developing hyperbilirubinemia
4
5
6
http://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPGhttp://c/Documents%20and%20Settings/STATION%20A/My%20Documents/Rona%20Feliciano/Desktop/Academe/NICU%20STUFF/chart%201%20colored.JPG -
7/27/2019 HYPERBILIRUBINEMIA.ppt
9/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
10/30
Perform a systematic assessment on all
infants before discharge for the risk of
severe hyperbilirubinemia
Provide parents with a written and
verbal information about newborn
jaundice
Provide appropriate follow-up based on
time of discharge and the risk
assessment
7
8
9
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
11/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
12/30
Pre-discharge TSB in the high-risk zone
Jaundice observed in the first 24 hours
Blood group incompatibility
Prematurity Cephalohematoma or significant bruising
Exclusive breastfeeding
East Asian race Previous sibling received phototherapy
Risk factors for development of Severe
Hyperbilirubinemia
............................................
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
13/30
Infant Discharged Should be seen by age
Before age 24 hours 72 hours
Between 24 48 hours 96 hours
Between 48- 72 hours 120 hours
Follow-up should be provided as
follows:
............................................
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
14/30
K E Y E L E M E N T S
Treat newborns, when indicated with
phototherapy or exchange transfusion
10
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
15/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
16/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
17/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
18/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
19/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
20/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
21/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
22/30
SUMMARY
Promote and support successful
breastfeeding
Perform a systematic assessment
before discharge for the risk of
hyperbilirubinemia
1
2
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
23/30
SUMMARY
Provide early and focused follow-up
based on the risk assessment
Treat newborns with phototherapy
or exchange transfusion when
indicated
3
4
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
24/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
25/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
26/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
27/30
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
28/30
Thank you!
PRACTICAL TIPS
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
29/30
PRACTICAL TIPS
Cover BOTH eyes and genitals formales. Cover only the eyes for females
Phototherapy must be at least 12
inches away from the chest Turn at least 2 3 hours to expose the
back and sides
Cepahlo-caudal progression
Remember bilirubin levels are
interpreted in HOURS
1
2
3
45
ANSWERS
-
7/27/2019 HYPERBILIRUBINEMIA.ppt
30/30
1. 35 or more weeks of gestation
2-3. 12 inches away from the infant's body; eyes
and genital with protective covering
4. 72 hours
5-6. Bilirubin > 25 mg/ml; bilirubin levels notdecreasing despite intensive phototherapy
7-10. RISK FACTORS for developing Severe
Hyperbilirubinemia
ANSWERS
............................................